Survey Among Healthcare Professionals Treating Patients With Metastatic Breast Cancer in Selected European Countries to Evaluate Their Knowledge on Management of Hyperglycemia When Using Alpelisib
Clinical trial NCT05073120 · COMPLETED
Trial details
- NCT number
- NCT05073120
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-02-28
- Primary completion
- 2024-06-05
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.